Back to Search
Start Over
PROGRESSION FREE SURVIVAL AT 12 MONTHS AFTER FIRST-LINE THERAPY IS ASSOCIATED WITH FAVOURABLE OUTCOMES AFTER FIRST RELAPSE/PROGRESSION IN PERIPHERAL T-CELL LYMPHOMA
- Source :
- Hematological Oncology. 37:469-470
- Publication Year :
- 2019
- Publisher :
- Wiley, 2019.
Details
- ISSN :
- 02780232
- Volume :
- 37
- Database :
- OpenAIRE
- Journal :
- Hematological Oncology
- Accession number :
- edsair.doi...........e47c12e91b8f69a346b8e06be79c1e50
- Full Text :
- https://doi.org/10.1002/hon.148_2631